IP Library Patent Application 14784860
Patent Application
App. No. 14/784,860

METHODS OF TREATMENT OF CARDIAC ARRHYTHMIAS USING VANOXERINE AND MODIFICATION OF DIET

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/784,860
Abstract

Disclosed embodiments are related to methods of treatment of cardiac arrhythmias comprising administration of vanoxerine (GBR 12909) in connection with food of a predetermined fat content to modulate the plasma level concentrations of vanoxerine in a patient.

Claims (37)

1 . A method for administering vanoxerine for treatment of cardiac arrhythmia comprising:

a. administering a first dose of vanoxerine to a patient;

b. determining the bioavailability of the patient by measuring the physiological concentration of vanoxerine;

c. calculating an effective dose of vanoxerine to be administered with a meal of a pre-determined fat content to be taken concurrently to modify the physiological concentration; and

d. administering the effective dose of vanoxerine with the pre-determined meal.

2 . The method of claim 1 wherein the meal has a fat content of at least 70 g and is taken directly before or concurrently with the vanoxerine dose.

3 . The method of claim 1 wherein the meal has a fat content of at least 50 g and is taken directly before or concurrently with the vanoxerine dose.

4 . The method of claim 1 wherein the meal has a fat content of at least 20 g and is taken directly before or concurrently with the vanoxerine dose.

5 . The method of claim 1 wherein the meal has a fat content of less than 10 g and is taken directly before or concurrently with the vanoxerine dose.

6 . The method of claim 1 wherein the meal is omitted and fasting is instituted with the effective dose of vanoxerine.

7 . A method for achieving a pre-determined plasma level comprising:

a. administering a first dose of vanoxerine concurrently with a high-fat meal;

b. measuring the physiological concentration of vanoxerine;

c. comparing the physiological concentration to the pre-determined physiological concentration;

d. modifying a further dose of vanoxerine to be given concurrently with a high-fat meal; and

e. administering the second dosage of vanoxerine in conjunction with the high-fat meal.

8 . The method of claim 7 wherein the pre-determined physiological concentration is taken two hours post administration.

9 . The method of claim 7 wherein the pre-determined physiological concentration is taken four hours post administration.

10 . The method of claim 7 wherein said high fat food comprises at least 20 g of fat.

11 . The method of claim 7 wherein said high fat food comprises at least 50 g of fat.

12 . The method of claim 7 wherein said high fat food comprises at least 70 g of fat.

13 . The method of claim 7 wherein said pre-determined physiological concentration is measured from the blood plasma.

14 . The method of claim 13 wherein the blood plasma concentration is greater than 60 ng/ml.

15 . A method of minimizing variability of physiological concentrations for treatment of cardiac arrhythmia with vanoxerine comprising:

a. determining a target physiological concentration;

b. administering a first dose of a drug comprising vanoxerine to a patient;

c. measuring the physiological concentration of vanoxerine in said patient; and

d. instructing patient to consume a high-fat meal concurrently with a further dose of vanoxerine.

16 . The method of claim 14 wherein said high-fat meal comprises at least 20 g of fat.

17 . The method of claim 14 wherein said high-fat meal comprises at least 50 g of fat.

18 . The method of claim 14 wherein said high-fat meal comprises at least 70 g of fat.

19 . The method of claim 14 further comprising the step of modifying the further dose of vanoxerine.

20 . A method of administration of vanoxerine to a patient comprising administering a first dose of vanoxerine to a patient under fasting conditions and administering a second dose of vanoxerine to said same patient about 1-2 hours after said first administration, wherein said second dose is taken concurrently with a high-fat meal.

21 . The method of claim 19 , wherein said first dose of vanoxerine is between 200 and 400 mg.

22 . The method of claim 19 , wherein said high-fat meal comprises at least 20 g of fat.

23 . The method of claim 19 , wherein said high-fat meal comprises at least 50 g of fat.

24 . The method of claim 19 , wherein said high-fat meal comprises at least 70 g of fat.